SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-032869
Filing Date
2019-06-28
Accepted
2019-06-28 08:00:29
Documents
10
Period of Report
2019-07-30
Effectiveness Date
2019-06-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv524043_def14a.htm DEF 14A 828536
2 GRAPHIC tv524043_img1.jpg GRAPHIC 3866
3 GRAPHIC tv524043_img2.jpg GRAPHIC 1855
4 GRAPHIC tv524043_img3.jpg GRAPHIC 45218
5 GRAPHIC tv524043_img4.jpg GRAPHIC 27251
6 GRAPHIC tv524043_img5.jpg GRAPHIC 50106
7 GRAPHIC tv524043_img6.jpg GRAPHIC 3093
8 GRAPHIC tv524043_img7.jpg GRAPHIC 259850
9 GRAPHIC tv524043_img8.jpg GRAPHIC 329484
10 GRAPHIC tv524043_img9.jpg GRAPHIC 204579
  Complete submission text file 0001144204-19-032869.txt   2105310
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

IRS No.: 201297589 | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32433 | Film No.: 19927334
SIC: 2834 Pharmaceutical Preparations